Serology
Leptospirosis serology
Clinical material provided (Liquid Serum – 0.5 mL) to assess the detection of Leptospirosis using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Leptospirosis IgG; IgM; Total Antibody; Leptospirosis Agglutination
Product details last updated on August 9, 2019
Lyme Disease serology
Clinical material provided (Liquid Serum / Plasma – 0.5 mL) to assess the detection of Lyme Disease using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Lyme Disease IgG Confirmatory; IgM Confirmatory; IgG; IgM; Total Antibody
Product details last updated on July 29, 2019
Measles serology
Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Measles using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Measles IgG; IgM; Total Antibody
Product details last updated on July 29, 2019
Mumps serology
Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Mumps using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Mumps IgG; IgM; Total Antibody
Product details last updated on July 29, 2019
Mycoplasma serology
Clinical material provided (Liquid Serum / Plasma – 0.5 mL) to assess the detection of Mycoplasma pneumoniae using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Mycoplasma IgA; IgG; IgM; Total Antibody
Product details last updated on July 29, 2019
Parvovirus serology
Clinical material provided (Liquid Serum / Plasma – 0.25 mL) to assess the detection of Parvovirus using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Parvovirus IgG, Parvovirus IgM
Product details last updated on August 9, 2019
Point of Care – Human immunodeficiency virus (HIV)
Clinical material provided (Stabilised Whole blood/ Inactivated viral culture lysate – 0.4 mL) to assess the detection of HIV using Point of Care Assays
Frequency / Number of samples
4 surveys / 2 samples per survey
Tests
HIV Antigen PoCT; HIV Antibody PoCT
Product details last updated on July 29, 2019
Point of Care – Influenza A & B Antigen
Simulated clinical material provided (Inactivated viral culture lysate – 0.5 mL) to assess the detection of Influenza antigen using Point of Care Assays
Frequency / Number of samples
4 surveys / 2 samples per survey
Tests
Influenza A Antigen PoCT; Influenza B Antigen PoCT
Product details last updated on July 29, 2019
Point of Care – RSV Antigen
Simulated clinical material provided (Inactivated viral culture lysate – 0.5 mL) to assess the detection of RSV antigen using Point of Care Assays
Frequency / Number of samples
4 surveys / 2 samples per survey
Tests
RSV Antigen PoCT
Product details last updated on July 29, 2019
Q fever serology
Clinical material provided (Liquid Serum / Plasma – 0.4 mL) to assess the detection of Q Fever using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Q fever Phase 1 IgA; IgG; IgM; Total Antibody
Q fever Phase 2 IgA; IgG; IgM; Total Antibody
Product details last updated on July 29, 2019
QuantiFERON – TB serology
Material provided (Lyophilised Serum / Plasma) to assess the detection of QuantiFERON® – TB
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
QuantiFERON® – TB (detection only)
Product details last updated on August 9, 2019
Rickettsia serology
Clinical material provided (Liquid Serum / Plasma – 0.4 mL) to assess the detection of various Rickettsial species using serological markers
Frequency / Number of samples
2 surveys / 2 samples per survey
Tests
Spotted Fever Group IgG; IgM; Total Antibody
Typhus Group Typhus Group IgG; Typhus Group IgM ;Total Antibody
Scrub Typhus Group IgG; IgM; Total Antibody
Product details last updated on August 9, 2019
